30 Miss. Code. R. 3002-5.1 - Grounds for Disciplinary Actions
A. The Board may
refuse to issue or renew, or may suspend, reprimand, revoke or restrict the
license, registration or permit of any person upon one or more of the
provisions listed in Mississippi Code Annotated Section
73-21-97.
B. Unprofessional conduct. Unprofessional
conduct shall include, but not be limited to:
1. The publication or circulation of false,
misleading, or otherwise deceptive statements concerning the practice of
pharmacy;
2. Attempting to
circumvent the patient counseling requirements, or discouraging the patient
from receiving patient counseling concerning their prescription drug
orders;
3. The illegal use or
disclosure of Protected Health Information (PHI) or other confidential patient
information; failure to maintain adequate records, systems, and security to
protect against the illegal use or disclosure of PHI or other confidential
patient information; or failure to maintain adequate records to account for
disclosures of PHI;
4. Dispensing,
selling, bartering, receiving or maintaining drugs or devices which are known
or should have been known to have been stolen or diverted from the purpose for
which they were distributed by a legitimate source;
5. Engaging in conduct likely to deceive,
defraud, or harm the public, or demonstrating a willful or careless disregard
for the health, welfare, or safety of a patient, or engaging in conduct which
substantially departs from the standards of care ordinarily exercised by a
pharmacist, with proof of actual injury not having to be established;
6. Selling a drug for which a prescription
drug order from a practitioner is required, without having received a valid
prescription drug order for the drug;
7. Failing to maintain complete and accurate
records of all drugs received, dispensed, or disposed of in compliance with the
Federal laws and regulations and State laws, rules and regulations;
8. Failure to report fraudulent prescription
activity to the Board or other appropriate authorities;
9. Obtaining any remuneration by fraud,
misrepresentation, or deception, including, but not limited to, receiving
remuneration for amending or modifying, or attempting to amend or modify, a
patient's pharmacist care services, absent a clear benefit to the
patient;
10. Filing a claim or
assisting in the filing of a claim for reimbursement for drugs or professional
services which were not provided, or which were not authorized to be
provided;
11. Condoning or
assisting in the dispensing, promotion, or distribution of drugs which do not
meet the standards required by law, or which the pharmacist knows, or should
know, are not obtained for legitimate medical need;
12. Destruction or alteration of any records
such as prescriptions, profiles, purchase invoices, third-party vouchers, and
receipts required to be kept;
13.
Selling or bartering a prescription drug sample;
14. Practicing in a location which is not
properly permitted or registered by the Mississippi Board of
Pharmacy;
C. Physical or
mental incapacity of a nature that prevents a pharmacist, a pharmacy
intern/extern, or a pharmacy technician from engaging in the practice of
pharmacy or assisting in the practice of pharmacy with reasonable skill,
confidence and safety to the public;
D. Violation of pharmacy or drug laws of any
other state or the federal government or the rules/regulations pertaining
thereto;
E. Violation of any of the
provisions of the Mississippi Uniform Controlled Substances Law;
F. Failing to report to the Board within
thirty (30) days any adverse action taken by another licensing jurisdiction,
government agency, law enforcement agency, or court that would constitute
grounds for action;
G. Failure to
immediately report directly to the Board, losses or suspected losses of
controlled substances or prescription drugs;
H. Knowing or suspecting that a Pharmacist or
Pharmacy Intern is incapable of engaging in the Practice of Pharmacy or that a
Pharmacy Technician is incapable of assisting in the practice of pharmacy, with
safety to the public, due to diversion or abuse of controlled substances or
prescription drugs and failing to report such relevant information to the
Board;
I. Theft or embezzlement of
prescription drugs, controlled substances, medical devices, funds or anything
of value;
J. Termination of
employees suspected of theft of pharmaceuticals, merchandise or anything of
value without contacting the Board prior to termination;
K. Addiction to or dependence on alcohol,
controlled substances or other habit-forming legend drugs or the unauthorized
use, possession or theft of controlled substances or other habit-forming legend
drugs;
L. Failure of a pharmacist
licensed by the Mississippi Board of Pharmacy to register as a user of the
Prescription Monitoring Program (PMP);
M. The unlawful disclosure of information
from the PMP or using information obtained from the PMP for unlawful or
unethical purposes;
N. Receiving,
dispensing, selling, bartering or maintaining a prescription drug sample unless
the pharmacy is owned by a charitable organization and is not operated for
profit and has prior approval in writing by the Board. Institutional pharmacies
may receive, dispense and maintain prescription drug samples that are provided
by a practitioner and intended solely for administration to his/her patients
confined to the institution provided no charge is made to the patient by the
institution for the sample;
O. No
pharmacist shall have possession of a prescription drug sample unless such
sample is for treatment of a diagnosed personal medical condition;
P. Jeopardizing, compromising, interfering or
failing to cooperate with any investigation conducted by the Board or any state
or federal regulatory or law enforcement agency;
Q. Failure to furnish the Board, its agents
or representatives any information requested by the Board, or retaliation for
providing information to the Board;
R. Destruction, removal or tampering with any
prescription drug, controlled substance, or medical device placed under seal,
embargoed, or quarantined by the Board or any representative of the
Board;
S. Any act by any person
which subverts the authority of the pharmacist-in-charge by impeding the
management of the prescription department or the practice of pharmacy in the
compliance with federal and state drug or pharmacy laws and
regulations;
T. Retaliation against
a pharmacist for practicing or attempting to practice pharmacy in compliance
with federal and state drug or pharmacy laws and regulations;
U. Retaliation against pharmacy employees for
providing information to the Board;
V. Hindering, interfering with, or
restricting the reporting of suspected unlawful activity to the appropriate
authorities;
W. Failure to produce
evidence of continuing education credits as required by regulation;
X. Failure by any representative of a
permitted facility to acknowledge completion of an inspection by placement of a
signature on the inspection form;
Y. Failure to comply with a subpoena issued
by the Board.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.